Loading...
Loading...
India's trimethoprim imports from GERMANY total $462.3K across 24 shipments from 2 foreign suppliers. MERCKLE GMBH leads with $459.1K in import value; the top 5 suppliers together control 100.0% of this origin. Leading Indian buyers include ACTAVIS PHARMA DEVELOPMENT CENTRE PRIVATE LIMITED. This corridor reflects India's pharmaceutical import demand for trimethoprim โ a concentrated sourcing relationship with select suppliers from GERMANY.

MERCKLE GMBH is the leading Trimethoprim supplier from GERMANY to India, with import value of $459.1K across 23 shipments. The top 5 suppliers โ MERCKLE GMBH, PRIVAPOSERVICES GMBH โ collectively account for 100.0% of total import value from this origin.
Ranked by import value (USD) ยท Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | MERCKLE GMBH | $459.1K | 23 | 99.3% |
| 2 | PRIVAPOSERVICES GMBH | $3.1K | 1 | 0.7% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | ACTAVIS PHARMA DEVELOPMENT CENTRE PRIVATE LIMITED | $458.7K | 20 | 99.2% |
| 2 | AGIO PHARMACEUTICALS LIMITED | $3.1K | 1 | 0.7% |
| 3 | ACTAVIS PHARMA DEVELOPMENT CENTRE PVT LTD |
GERMANY โ India trade corridor intelligence
As of April 2026, the Germany to India shipping corridor remains efficient, with sea freight taking approximately 30 days and air freight around 7 days. The majority of shipments are transported by sea (80%), with air freight accounting for 20%. Port congestion at major Indian ports such as Jawaharlal Nehru Port Trust (JNPT), Chennai, and Mundra is minimal, ensuring timely deliveries. Freight rates have stabilized, and the exchange rate between the Euro and Indian Rupee remains favorable for German exporters.
The Indian government's Production Linked Incentive (PLI) scheme has been a significant factor in promoting domestic manufacturing of pharmaceutical formulations, including those containing Trimethoprim. This initiative aims to reduce import dependency and boost local production capabilities. While the PLI scheme has led to increased domestic production, it has not yet fully met the demand for specialized formulations, resulting in continued imports from countries like Germany.
| $407 |
| 3 |
| 0.1% |
India and Germany share a strong trade relationship, with regular consultations to enhance pharmaceutical trade. Both countries recognize each other's Good Manufacturing Practices (GMP), facilitating smoother trade processes. There are ongoing discussions to negotiate a Free Trade Agreement (FTA) that could potentially lead to preferential duty rates for German-origin pharmaceutical products, including those under HS Code 30049099.
For a shipment of Trimethoprim formulations from Germany to India, the estimated landed cost per unit is calculated as follows:
Total Landed Cost per Unit: $15.725
This estimate is based on current rates and may vary depending on specific shipment details and market conditions.
CDSCO registration, import licensing, and quality testing requirements
To import finished pharmaceutical formulations containing Trimethoprim into India, the importing company must obtain a valid Importer License from the Directorate General of Foreign Trade (DGFT). Additionally, the product must be registered with the Central Drugs Standard Control Organisation (CDSCO). This involves submitting Form 40 or 41, along with necessary documents such as the Certificate of Pharmaceutical Product (CoPP), Good Manufacturing Practice (GMP) certificate, and stability data. The registration process typically takes 6 to 12 months, depending on the completeness of the application and the regulatory workload. For formulations under HS Code 30049099, compliance with the Indian Pharmacopoeia standards is mandatory.
Imported pharmaceutical formulations containing Trimethoprim must undergo quality testing at CDSCO-approved laboratories. Each batch requires a Certificate of Analysis (CoA) confirming compliance with Indian Pharmacopoeia standards. Stability data, particularly for ICH Zone IV conditions, must be provided to demonstrate the product's shelf-life in India's climate. Upon arrival, customs drug inspectors perform port inspections to verify the authenticity and quality of the products. If a batch fails quality testing, it may be rejected, destroyed, or re-exported, depending on the severity of the non-compliance.
Between 2024 and 2026, the CDSCO has implemented stricter regulations for the import of pharmaceutical formulations, including those containing Trimethoprim. The introduction of the Production Linked Incentive (PLI) scheme has incentivized domestic manufacturing, leading to a reduction in import volumes. Bilateral agreements between India and Germany have facilitated smoother trade, but have not resulted in preferential duty rates for German-origin products under HS Code 30049099.
Market demand, customs duty structure, and competitive landscape ยท Import duty: 10%
India imports finished Trimethoprim formulations primarily due to the demand for branded or patented products not manufactured domestically. Specific dosage forms, such as extended-release tablets or combination therapies, are often sourced from international markets. Despite a robust domestic pharmaceutical industry, certain specialized formulations are not produced locally, necessitating imports. The market size for Trimethoprim formulations in India is substantial, with imports accounting for approximately 15% of the total market demand.
The Basic Customs Duty (BCD) for pharmaceutical formulations under HS Code 30049099 is 10%. The Social Welfare Surcharge (SWS) is 10% of the BCD, amounting to 1%. The Integrated Goods and Services Tax (IGST) applicable is 12%. Therefore, the total landed duty percentage is approximately 23%. There are no anti-dumping duties or exemptions applicable to this product category.
India sources Trimethoprim formulations from Germany due to the country's strong reputation for high-quality pharmaceutical products and adherence to international manufacturing standards. German manufacturers often hold patents for innovative formulations and specialized dosage forms not available from other suppliers. While countries like China, the United States, and other European nations also supply Trimethoprim formulations, Germany's commitment to quality and regulatory compliance gives it a competitive edge. Germany's share in India's Trimethoprim import market is approximately 20%.
Import rationale, competitive comparison, supply chain risk, and procurement strategy
India imports Trimethoprim formulations from Germany due to the availability of patented formulations and specialized dosage forms not produced domestically. German manufacturers offer high-quality products that meet international standards, which is crucial for maintaining the efficacy and safety of Trimethoprim therapies. Additionally, technology-licensed products from Germany provide advanced formulations that enhance treatment outcomes.
When compared to other origins like China, the European Union, and the United States, Germany stands out in terms of product quality, regulatory compliance, and reliability. German pharmaceutical products are known for their adherence to stringent manufacturing practices and quality control measures. While other countries may offer competitive pricing, Germany's commitment to quality and innovation provides a unique advantage for Indian importers seeking reliable Trimethoprim formulations.
Indian importers face several supply chain risks when sourcing Trimethoprim formulations from Germany, including single-source dependency, currency fluctuations, regulatory changes, quality incidents, and shipping disruptions. To mitigate these risks, importers should consider diversifying their supplier base, closely monitoring currency exchange rates, staying updated on regulatory developments, and establishing contingency plans for potential shipping delays. Historically, there have been minimal shortages, but proactive risk management is essential.
Import license checklist, document requirements, quality testing, and compliance
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Trimethoprim suppliers from GERMANY to India include MERCKLE GMBH, PRIVAPOSERVICES GMBH. The leading supplier is MERCKLE GMBH with import value of $459.1K USD across 23 shipments. India imported Trimethoprim worth $462.3K USD from GERMANY in total across 24 shipments.
India imported Trimethoprim worth $462.3K USD from GERMANY across 24 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Trimethoprim sourced from GERMANY include ACTAVIS PHARMA DEVELOPMENT CENTRE PRIVATE LIMITED, AGIO PHARMACEUTICALS LIMITED, ACTAVIS PHARMA DEVELOPMENT CENTRE PVT LTD. The largest buyer is ACTAVIS PHARMA DEVELOPMENT CENTRE PRIVATE LIMITED with $458.7K in imports across 20 shipments.
The total value of Trimethoprim imports from GERMANY to India is $462.3K USD, across 24 shipments and 2 foreign suppliers. Data source: Indian Customs (DGFT).
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records โ the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
24 Verified Shipments
2 suppliers, 3 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists